Autologe immuuncel therapie, toegepast in Japan, helpt nu het Vinmec-ziekenhuis bij de behandeling van kankerpatiënten in Hanoi, Vietnam, na technologieoverdracht door GN Corporation

Hyperthermiesysteem gemaakt in Japan, ten goede aan kankerpatiënten, trekt de aandacht van overzeese kankerziekenhuizen.

NK cells and T-cells in vitro culture method, without feeder cells or animal serum or genetic manipulation, for immune-cell therapy to cancer patients developed and practiced in Japan was tech-transferred to Vinmec Hospital, Hanoi, Vietnam, which was accomplished in phases viz., (i) Cell processing facility infrastructure and equipment advisory, (ii) Training of biotechnologists from Vietnam in Japan, (iii) On-site, technical support in Vinmec hospital lab by Japanese experts (iv) Educational seminars to physicians, oncologists and (v) Interaction with regulatory authority in Japan, the PMDA and MHLW; spearheaded by GNC Japan. Immune-cell therapy with Thermotron RF8-EX radiofrequency hyperthermia, when added to conventional cancer treatment, yields increase in survival of cancer patients. These safety proven treatments practiced for long in Japan to manage most of the solid tumours are of interest to many cancer hospitals overseas to add them to their existing oncology services. (Graphic: Business Wire)

  • NK cells and T-cells in vitro culture method, without feeder cells or animal serum or genetic manipulation, for immune-cell therapy to cancer patients developed and practiced in Japan was tech-transferred to Vinmec Hospital, Hanoi, Vietnam, which was accomplished in phases viz., (i) Cell processing facility infrastructure and equipment advisory, (ii) Training of biotechnologists from Vietnam in Japan, (iii) On-site, technical support in Vinmec hospital lab by Japanese experts (iv) Educational seminars to physicians, oncologists and (v) Interaction with regulatory authority in Japan, the PMDA and MHLW; spearheaded by GNC Japan. Immune-cell therapy with Thermotron RF8-EX radiofrequency hyperthermia, when added to conventional cancer treatment, yields increase in survival of cancer patients. These safety proven treatments practiced for long in Japan to manage most of the solid tumours are of interest to many cancer hospitals overseas to add them to their existing oncology services. (Graphic: Business Wire)

TOKIO--()--Behandeling van kanker met behulp van de eigen immuuncellen, natural killer (NK)-cellen en T-cellen, autologous immune enhancement cell therapy (AIET) genoemd, toegediend samen met conventionele chemotherapie, radiotherapie en chirurgie, toegepast in Japan voor long wordt nu aangeboden in het Vinmec-ziekenhuis, Hanoi, Vietnam, na technologieoverdracht door GN Corporation. Voor deze behandeling komen nu kankerpatiënten uit omringende landen naar het Vinmec ziekenhuis. Autologe immuun celtherapie, gereguleerd door de regeneratieve geneeskundewet in Japan, maakt gebruik van in het laboratorium uitgebreide autologe immuuncellen, zonder dierlijke eiwitten of genetische manipulatie.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldig is.

Contacts

Samuel JK Abraham
info@gncorporation.com

Contacts

Samuel JK Abraham
info@gncorporation.com